United States Pharmaceuticals

Mylan NV (MYL)

Track

Ticker: MYL Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
PARRISH MARK W
1 purchase — total 209,830 USD
Buy 11 Aug 2020
Value US$3,439,483.19 | Price 78.47 | Shares 93,935
Planned sale 5 Feb 2020
Value US$4,713,049.58 | Price 48.81 | Shares 74,621
Buy 15 Aug 2019
Value US$353,548.00 | Price 17.68 | Shares 20,000
Buy 14 Aug 2019
Value US$201,188.90 | Price 18.29 | Shares 11,000
Buy 14 Aug 2019
Value US$250,250.00 | Price 19.25 | Shares 13,000
Buy 13 Aug 2019
Value US$191,100.00 | Price 19.11 | Shares 10,000
Buy 2 Aug 2019
Value US$1,000,011.99 | Price 20.06 | Shares 49,859
Buy 31 Jul 2019
Value US$83,873.60 | Price 20.97 | Shares 4,000
Planned sale 4 Mar 2019
Value US$317,142.51 | Price 27.50 | Shares 11,533
Sale 6 Mar 2018
Value US$2,170,685.00 | Price 43.41 | Shares 50,000
Sale 6 Mar 2018
Value US$309,390.30 | Price 44.01 | Shares 7,030
Sale 2 Mar 2018
Value US$494,569.95 | Price 40.35 | Shares 12,257
Sale 2 Mar 2018
Value US$2,045,695.00 | Price 40.91 | Shares 50,000
Sale 2 Mar 2018
Value US$6,014,625.00 | Price 40.10 | Shares 150,000
Planned sale 9 Jan 2018
Value US$1,391,985.00 | Price 45.00 | Shares 30,933
Planned sale 8 Jan 2018
Value US$1,983,015.00 | Price 45.00 | Shares 44,067
Planned sale 9 Jun 2017
Value US$1,000,000.00 | Price 40.00 | Shares 25,000
Planned sale 9 Jun 2017
Value US$400,000.00 | Price 40.00 | Shares 10,000
Sale 23 Mar 2017
Value US$1,830,400,000.00 | Price 41.60 | Shares 44,000,000
Planned sale 9 Aug 2016
Value US$5,010,000.00 | Price 50.00 | Shares 100,200
Buy 6 Jun 2016
Value US$769,859.48 | Price 46.52 | Shares 16,549
Planned buy 3 Jun 2016
Value US$75,066.50 | Price 44.95 | Shares 1,670
Buy 3 Jun 2016
Value US$75,066.50 | Price 44.95 | Shares 1,670
Planned buy 25 May 2016
Value US$50,539.30 | Price 42.47 | Shares 1,190
Planned buy 25 May 2016
Value US$100,653.90 | Price 42.47 | Shares 2,370
Buy 25 May 2016
Value US$50,539.30 | Price 42.47 | Shares 1,190
Buy 25 May 2016
Value US$100,653.90 | Price 42.47 | Shares 2,370
Planned buy 12 May 2016
Value US$769,724.04 | Price 38.68 | Shares 19,900
Buy 12 May 2016
Value US$769,732.00 | Price 38.68 | Shares 19,900
Planned buy 6 May 2016
Value US$3,869.00 | Price 38.69 | Shares 100
Buy 6 May 2016
Value US$3,869.00 | Price 38.69 | Shares 100
Planned buy 28 Apr 2016
Value US$1,502,137.00 | Price 42.92 | Shares 35,000
Buy 28 Apr 2016
Value US$1,502,200.00 | Price 42.92 | Shares 35,000
Planned sale 5 Apr 2016
Value US$10,007,170.56 | Price 45.96 | Shares 217,755
Planned buy 31 Mar 2016
Value US$201,057.68 | Price 46.36 | Shares 4,337
Buy 31 Mar 2016
Value US$193,135.76 | Price 46.36 | Shares 4,166
Buy 31 Mar 2016
Value US$4,634.00 | Price 46.34 | Shares 100
Buy 31 Mar 2016
Value US$3,288.01 | Price 46.31 | Shares 71
Sale 24 Mar 2016
Value US$99,992.40 | Price 30.90 | Shares 3,236
Sale 24 Mar 2016
Value US$299,995.74 | Price 22.66 | Shares 13,239
Sale 24 Mar 2016
Value US$500,065.51 | Price 24.11 | Shares 20,741
Planned buy 17 Mar 2016
Value US$75,020.00 | Price 44.00 | Shares 1,705
Buy 17 Mar 2016
Value US$75,020.00 | Price 44.00 | Shares 1,705
Planned buy 8 Mar 2016
Value US$100,056.06 | Price 45.69 | Shares 2,190
Buy 8 Mar 2016
Value US$100,061.10 | Price 45.69 | Shares 2,190
Planned buy 3 Mar 2016
Value US$100,229.99 | Price 45.83 | Shares 2,187
Buy 3 Mar 2016
Value US$100,230.21 | Price 45.83 | Shares 2,187
Buy 17 Feb 2016
Value US$499,073.30 | Price 45.37 | Shares 11,000
Buy 17 Feb 2016
Value US$1,263,818.78 | Price 46.27 | Shares 27,314
Planned sale 17 Dec 2015
Value US$1,315,639.95 | Price 55.05 | Shares 23,899
Sale 17 Dec 2015
Value US$1,315,639.95 | Price 55.05 | Shares 23,899
Sale 15 Dec 2015
Value US$587,400.00 | Price 55.00 | Shares 10,680
Sale 15 Jun 2015
Value US$610,291.08 | Price 73.08 | Shares 8,351
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-08-12 2020-08-11 B Purchase
3.2
PARRISH MARK W
Non-Executive Director
93,935 -32.1%
78.47
US$3,439,483 		93,935 -32.1% 78.47 US$3,439,483
2020-02-07 2020-02-05 PlS Planned sale
3.1
Campbell Paul

See Remarks

Officer
74,621 +38.5%
48.81
US$4,713,050 		74,621 +38.5% 48.81 US$4,713,050
2019-08-19 2019-08-15 B Purchase HIGGINS MELINA E Non-Executive Director
17,776 -23.9%
32.85
US$1,622,153 		17,776 -23.9% 32.85 US$1,622,153
2019-08-15 2019-08-14 B Purchase Vollebregt Sjoerd S Non-Executive Director
11,000 +35.2%
18.29
US$201,189 		11,000 +35.2% 18.29 US$201,189
2019-08-15 2019-08-14 B Purchase Vollebregt Sjoerd S Non-Executive Director
13,000 +71.2%
19.25
US$250,250 		13,000 +71.2% 19.25 US$250,250
2019-08-15 2019-08-13 B Purchase Vollebregt Sjoerd S Non-Executive Director
10,000 +121.1%
19.11
US$191,100 		10,000 +121.1% 19.11 US$191,100
2019-08-05 2019-08-02 B Purchase COURY ROBERT J Non-Executive Director
49,859 +5.6%
20.06
US$1,000,012 		49,859 +5.6% 20.06 US$1,000,012
2019-08-02 2019-07-31 B Purchase MARK RICHARD A Non-Executive Director
4,000 +inf%
20.97
US$83,874 		4,000 +inf% 20.97 US$83,874
2019-03-05 2019-03-04 PlS Planned sale
3.1
Campbell Paul

See Remarks

Officer
11,533 -32.3%
27.50
US$317,143 		11,533 -32.3% 27.50 US$317,143
2018-03-06 2018-03-06 S Sale COURY ROBERT J
50,000 -15.6%
43.41
US$2,170,685 		50,000 -15.6% 43.41 US$2,170,685
2018-03-06 2018-03-06 S Sale Campbell Paul

See Remarks
7,030 -28.6%
44.01
US$309,390 		7,030 -28.6% 44.01 US$309,390
2018-03-06 2018-03-02 S Sale Mauro Anthony

Chief Commercial Officer
12,257 -8.3%
40.35
US$494,570 		12,257 -8.3% 40.35 US$494,570
2018-03-06 2018-03-02 S Sale Malik Rajiv

President

Executive Director
50,000 -9.0%
40.91
US$2,045,695 		50,000 -9.0% 40.91 US$2,045,695
2018-03-06 2018-03-02 S Sale COURY ROBERT J
150,000 -31.8%
40.10
US$6,014,625 		150,000 -31.8% 40.10 US$6,014,625
2018-01-10 2018-01-09 PlS Planned sale BRESCH HEATHER M

Chief Executive Officer

Executive Director
30,933 -6.0%
45.00
US$1,391,985 		30,933 -6.0% 45.00 US$1,391,985
2018-01-10 2018-01-08 PlS Planned sale BRESCH HEATHER M

Chief Executive Officer

Executive Director
44,067 -7.9%
45.00
US$1,983,015 		44,067 -7.9% 45.00 US$1,983,015
2017-06-09 2017-06-09 PlS Planned sale Malik Rajiv

President

Executive Director
25,000 -3.0%
40.00
US$1,000,000 		25,000 -3.0% 40.00 US$1,000,000
2017-06-09 2017-06-09 PlS Planned sale Mauro Anthony

Chief Commercial Officer
10,000 -6.6%
40.00
US$400,000 		10,000 -6.6% 40.00 US$400,000
2017-03-24 2017-03-23 S Sale ABBOTT LABORATORIES Large shareholder
44,000,000 -63.1%
41.60
US$1,830,400,000 		44,000,000 -63.1% 41.60 US$1,830,400,000
2016-08-11 2016-08-09 PlS Planned sale BRESCH HEATHER M

Chief Executive Officer

Executive Director
100,200 -10.8%
50.00
US$5,010,000 		100,200 -10.8% 50.00 US$5,010,000
2016-06-06 2016-06-06 B Purchase Parks K.S.
16,549
46.52
US$769,859 		16,549 46.52 US$769,859
2016-06-06 2016-06-03 PP Planned purchase MAROON JOSEPH C MD Non-Executive Director
1,670 +8.2%
44.95
US$75,066 		1,670 +8.2% 44.95 US$75,066
2016-06-03 2016-06-03 B Purchase Maroon Joseph C.
1,670
44.95
US$75,066 		1,670 44.95 US$75,066
2016-05-25 2016-05-25 PP Planned purchase Cindrich Robert J Non-Executive Director
1,190 +9.8%
42.47
US$50,539 		1,190 +9.8% 42.47 US$50,539
2016-05-25 2016-05-25 PP Planned purchase MAROON JOSEPH C MD Non-Executive Director
2,370 +13.2%
42.47
US$100,654 		2,370 +13.2% 42.47 US$100,654
2016-05-25 2016-05-25 B Purchase Cindrich R.J.
1,190
42.47
US$50,539 		1,190 42.47 US$50,539
2016-05-25 2016-05-25 B Purchase Maroon Joseph C.
2,370
42.47
US$100,654 		2,370 42.47 US$100,654
2016-05-16 2016-05-12 PP Planned purchase
HIGGINS MELINA E
Non-Executive Director
19,900 +36.8%
38.68
US$769,724 		19,900 +36.8% 38.68 US$769,724
2016-05-12 2016-05-12 B Purchase Willinge J.
19,900
38.68
US$769,732 		19,900 38.68 US$769,732
2016-05-09 2016-05-06 PP Planned purchase
HIGGINS MELINA E
Non-Executive Director
100 +0.2%
38.69
US$3,869 		100 +0.2% 38.69 US$3,869
2016-05-06 2016-05-06 B Purchase Willinge J.
100
38.69
US$3,869 		100 38.69 US$3,869
2016-04-29 2016-04-28 PP Planned purchase HIGGINS MELINA E Non-Executive Director
35,000 +184.2%
42.92
US$1,502,137 		35,000 +184.2% 42.92 US$1,502,137
2016-04-28 2016-04-28 B Purchase Willinge J.
35,000
42.92
US$1,502,200 		35,000 42.92 US$1,502,200
2016-04-07 2016-04-05 PlS Planned sale COURY ROBERT J

Executive Chairman

Executive Director
217,755 -14.0%
45.96
US$10,007,171 		217,755 -14.0% 45.96 US$10,007,171
2016-04-04 2016-03-31 PP Planned purchase MAROON JOSEPH C MD Non-Executive Director
4,337 +36.8%
46.36
US$201,058 		4,337 +36.8% 46.36 US$201,058
2016-03-31 2016-03-31 B Purchase Maroon Joseph C.
4,166
46.36
US$193,136 		4,166 46.36 US$193,136
2016-03-31 2016-03-31 B Purchase Maroon Joseph C.
100
46.34
US$4,634 		100 46.34 US$4,634
2016-03-31 2016-03-31 B Purchase Maroon Joseph C.
71
46.31
US$3,288 		71 46.31 US$3,288
2016-03-24 2016-03-24 S Sale Sheehan J.D.
3,236
30.90
US$99,992 		3,236 30.90 US$99,992
2016-03-24 2016-03-24 S Sale Sheehan J.D.
13,239
22.66
US$299,996 		13,239 22.66 US$299,996
2016-03-24 2016-03-24 S Sale Sheehan J.D.
20,741
24.11
US$500,066 		20,741 24.11 US$500,066
2016-03-18 2016-03-17 PP Planned purchase PARRISH MARK W Non-Executive Director
1,705 +5.7%
44.00
US$75,020 		1,705 +5.7% 44.00 US$75,020
2016-03-17 2016-03-17 B Purchase Parrish M.W.
1,705
44.00
US$75,020 		1,705 44.00 US$75,020
2016-03-09 2016-03-08 PP Planned purchase CAMERON WENDY Non-Executive Director
2,190 +3.4%
45.69
US$100,056 		2,190 +3.4% 45.69 US$100,056
2016-03-08 2016-03-08 B Purchase Wendy Cameron Recovable Trust
2,190
45.69
US$100,061 		2,190 45.69 US$100,061
2016-03-03 2016-03-03 PP Planned purchase Cindrich Robert J Non-Executive Director
2,187 +26.9%
45.83
US$100,230 		2,187 +26.9% 45.83 US$100,230
2016-03-03 2016-03-03 B Purchase Cindrich R.J.
2,187
45.83
US$100,230 		2,187 45.83 US$100,230
2016-02-19 2016-02-17 B Purchase LEECH DOUGLAS J Non-Executive Director
11,000 +35.1%
45.37
US$499,073 		11,000 +35.1% 45.37 US$499,073
2016-02-17 2016-02-17 B Purchase Mauro A.
27,314
46.27
US$1,263,819 		27,314 46.27 US$1,263,819
2015-12-17 2015-12-17 PlS Planned sale SHEEHAN JOHN D

EVP and CFO

Officer
23,899 -12.2%
55.05
US$1,315,640 		23,899 -12.2% 55.05 US$1,315,640
2015-12-17 2015-12-17 S Sale Sheehan J.D.
23,899
55.05
US$1,315,640 		23,899 55.05 US$1,315,640
2015-12-15 2015-12-15 S Sale Sheehan J.D.
10,680
55.00
US$587,400 		10,680 55.00 US$587,400
2015-06-15 2015-06-15 S Sale Higgins M.E.
8,351
73.08
US$610,291 		8,351 73.08 US$610,291
Explore more

More insider trading research around Mylan NV

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America